AngioDynamics | ANGO - Cash And Equivalent


AngioDynamics reported $41.64M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Accuray USD 41.29M 22.05M Dec/2025
AngioDynamics USD 41.64M 14.26M Sep/2025
Artivion USD 77.32M 21.55M Jun/2026
AtriCure USD 167.79M 21.62M Jun/2026
Boston Scientific USD 539M 914M Jun/2026
Edwards Lifesciences USD 2.9B 500M Jun/2026
ICU Medical USD 288.33M 19.63M Mar/2026
Inogen USD 106.48M 2.79M Sep/2025
J&J USD 20.42B 1.27B Jun/2026
Medtronic USD 1.69B 258M Jun/2026
Merit Medical Systems USD 448.7M 39.38M Jun/2026
Mesa Laboratories USD 28.98M 8.55M Dec/2025
Orthofix International USD 103.81M 16.47M Jun/2026
Smiths GBP 345M 47M Dec/2025
Tandem Diabetes Care USD 62.82M 116.51M Jun/2026
Teleflex USD 300.16M 9.25M Jun/2026
Terumo JPY 280.49B 63.34B Mar/2026
Trinity Biotech USD 5.14M 3.8M Dec/2025